VAN TUYL CHRISTOPHER (Chief Legal Officer) sold 9.0% of their position (17.82K shares) of IMMUNOVANT, INC. on the open market
Open‑market sale worth $682.9K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 6/26/2026ACC: 0001764013-26-000073
Officer· Chief Legal Officer
Since Dec 2024
-17.82K
Net shares
Net seller
$682.9K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
17.82K acquired · 35.65K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+17.82K
Price / share
$15.20
Trade value
$270.92K
% of position
9.9%
6/26/2026
180.60K→198.42K
Common Stock
Direct
Shares
−14.98K
Price / share
$38.19
Trade value
$572.16K
% of position
7.6%
6/26/2026
198.42K→183.44K
Common Stock
Direct
Shares
−2.84K
Price / share
$38.96
Trade value
$110.72K
% of position
1.5%
6/26/2026
183.44K→180.60K
Total
Net shares
+0.00
Net value
-$411.96K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/26/2026 | M · Option Exercise | +17.82K | $15.20 | $270.92K | 9.9% | 180.60K | 198.42K |
| Common Stock Direct | 6/26/2026 | S · Sale | −14.98K | $38.19 | $572.16K | 7.6% | 198.42K | 183.44K |
| Common Stock Direct | 6/26/2026 | S · Sale | −2.84K | $38.96 | $110.72K | 1.5% | 183.44K | 180.60K |
| Total | +0.00 | -$411.96K | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
17.82K shares
Shares
−17.82K
Strike price
15.20
Held after
53.71K
Exercisable
—
6/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock17.82K shares | 6/26/2026 | M · Option Exercise | −17.82K | 15.20 | — | 53.71K |